MOLBIO DIAGNOSTICS LTD is a listed company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated |
|---|
| Revenue |
| EBITDA (ex other income) |
| margin % |
| Owners' profit |
| EPS, as reported (₹) |
| ROE % · ROCE % |
| Debt / equity (x) |
| Cash from operations |
| Capex |
| ₹ crore | Q1 FY27 |
|---|---|
| Revenue | 408 |
| Profit before tax | 76 |
| Net profit | 53 |
| EPS (₹) | 5.21 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 9 Sept 2026 · CIN changed to reflect listed company status after NSE/BSE listing | compliance | minimal | — | — |
| 8 Sept 2026 · Audio recording of Q1 FY27 earnings call uploaded on company website | investor communications | low | — | — |
| 8 Sept 2026 · Molbio Q1 FY27 Investor Presentation: Strong Revenue and Profitability Growth | investor communications | medium | — | — |
| 7 Sept 2026 · Newspaper publication of Q1 FY27 unaudited financial results | compliance | minimal | — | — |
| 7 Sept 2026 · Molbio Diagnostics Q1 FY27: Revenue Rs 411 Cr, swings to Rs 53 Cr profit | results | high | — | — |
| 5 Sept 2026 · Molbio Q1 FY27: Revenue Rs 399cr, PAT Rs 56.6cr; first listed results | results | high | — | — |
| 2 Sept 2026 · Molbio Diagnostics Q1 FY27 earnings call on 8 Sept 2026 | board shareholder meetings | low | — | — |
| 1 Sept 2026 · Board meeting on Sep 5 to approve Q1 FY27 results | results | low | — | — |
| 27 Aug 2026 · Board meeting: Compliance Officer designated under Insider Trading rules | management changes | low | — | — |
| 20 Aug 2026 · Trading window closes for insiders ahead of Q1 results | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
